article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

She has been on an antipsychotic medication to treat her bipolar disorder for 10 years, resulting in stability of mood symptoms that were previously poorly controlled. In 2022, a panel of TD experts developed a standardized tool that could be utilized easily in a clinical setting to assess TD’s impact on functioning in various domains.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

link] Related Videos Related Content Advertisement May 29th 2025 Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists Leah Kuntz April 9th 2022 Here's to a Psychedelic Revolution Amir Inamdar MBBS, DNB (Psych), MFPM May 23rd 2025 Looking Ahead to the ASCP Annual Meeting With Joseph F.

Education 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

News Media Around the Practice Between the Lines PsychView Expert Perspectives Case-Based Psych Perspectives Clinical Case Collective Dialogues Payer-Provider Perspective Slideshows Videos Viewpoints Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Clinical Consult Clinical (..)

article thumbnail

Psychotherapy and Psychosomatics: End of an Era for Independent Journals? An Interview With Giovanni Fava

Mad in America

From 1992 to 2022, Dr. Fava edited the journal Psychotherapy and Psychosomatics. When he resigned as editor in 2022, it had an impact factor that made it one of the most influential journals in psychiatry and psychology. He left the journal in good hands in 2022 and he remained involved as an honorary editor.

article thumbnail

Self Stolen: How ECT Fried My Brain

Mad in America

O n the evening of December 3, 2022, I overdosed on 400 mg of Amlodipine, a calcium channel blocker blood pressure medicine. I tried going back to school after the brain injury, but between the bipolar disorder and the head trauma, I couldn’t handle the stress and pressure anymore. So to back way up, as a kid I was brilliant.

article thumbnail

New Guidelines on How to Accurately Convey ADHD Information

Mad in America

Receiving a slow but positive reception in the Netherlands in 2022 and 2023, several additional practitioners in the field of psychiatry and psychology committed to translating the guidelines to English, resulting in the current revised and stylized version.

article thumbnail

Mood Tracking: My System for Reducing Psychiatric Hospitalizations

Mad in America

I was first diagnosed with bipolar disorder in 1998. Around the 2016 hospitalization my diagnosis was elevated to schizoaffective disorder and I was placed on everyday Zyprexa. By 2022, I had recovered to such a degree that I decided I wanted to come off the Depakote. After 2016, my need for hospitalization declined.